Our findings indicate that lactate/GPR81 signaling protects the integrity of the intestinal epithelial barrier and may alleviate colitis symptoms, possibly by inhibiting the activation of NF-κB/MMP9 pathways. The gene discussed is MMP9; the disease is colitis.